Health Care & Life Sciences » Pharmaceuticals | FDC Ltd.

FDC Ltd. | Balance Sheet

Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
Cash & Short Term Investments
2,522
2,875
3,034
4,650
4,265
Total Accounts Receivable
779
759
710
838
908
Inventories
1,030
1,232
1,309
1,438
1,679
Other Current Assets
155
155
180
2,258
3,047
Total Current Assets
4,486
5,021
5,234
9,183
9,899
Net Property, Plant & Equipment
3,089
4,210
6,941
6,786
6,822
Total Investments and Advances
3,060
2,212
394
546
741
Long-Term Note Receivable
-
2
2
2
1
Intangible Assets
28
23
39
98
81
Other Assets
22
16
48
2,147
2,122
Total Assets
10,728
11,525
12,727
18,842
19,750
ST Debt & Current Portion LT Debt
16
12
1
1
1
Accounts Payable
788
872
826
779
999
Income Tax Payable
168
1
103
2,253
2,864
Other Current Liabilities
951
995
704
861
926
Total Current Liabilities
1,923
1,880
1,634
3,894
4,790
Long-Term Debt
11
9
8
7
6
Provision for Risks & Charges
-
6
5
4
4
Deferred Taxes
299
226
186
174
152
Other Liabilities
-
-
-
1,982
1,953
Total Liabilities
2,275
2,161
1,902
6,140
6,989
Common Equity (Total)
8,453
9,364
10,825
12,702
12,761
Total Shareholders' Equity
8,453
9,364
10,825
12,702
12,761
Total Equity
8,453
9,364
10,825
12,702
12,761
Liabilities & Shareholders' Equity
10,728
11,525
12,727
18,842
19,750

About FDC

View Profile
Address
142-48, S. V. Road
Mumbai Maharashtra 400102
India
Employees -
Website http://www.fdcindia.com
Updated 09/14/2018
FDC Ltd. engages in the business of pharmaceutical. It presence in therapeutic segments, such as, anti-infectives, gastrointestinals, ophthalmologicals, vitamins, minerals, dietary supplements, cardiac, anti-diabetes, respiratory, gynaecology, dermatology, analgesics and others. The company products are sold under brand names, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl and Mycoderm.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.